Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using AI imaging to improve blood sugar control in diabetic patients

Official title: The Impact of AI-Based Fundus Imaging on Blood Glucose Control and Fundus Examination Completion Rates in Outpatient Diabetic Patients

Run by Sichuan Provincial People's Hospital · NCT06819423 · Data updated 2026-11-12

This study is testing whether using AI imaging can help people with diabetes better control their blood sugar and get more eye exams done.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorSichuan Provincial People's Hospital
Academic / other
Locations1 site (Chengdu, Sichuan)
StatusRecruiting
StartedDecember 26, 2024
Main results expectedDecember 26, 2025
Study endsDecember 26, 2025
Registry record updatedFebruary 11, 2025
Trial IDNCT06819423 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with Type 2 Diabetes Mellitus and an HbA1c level greater than 7%.

Probably not a fit

Patients without a prior diabetic fundus examination or those with known diabetic retinopathy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates how AI-based fundus imaging affects blood glucose control and the completion rates of eye examinations in diabetic patients. It involves a randomized controlled trial with 200 participants, divided into an intervention group receiving AI imaging and a control group receiving standard education. The primary outcomes measured will include blood glucose levels and the rates of completed fundus examinations. The study is conducted at Sichuan Provincial People's Hospital over a one-year period.

Why it matters

Potential benefit: If successful, this approach could enhance blood glucose management and increase the rate of necessary eye examinations for diabetic patients.

How similar studies have gone: Other studies have shown promising results with AI imaging in diabetic care, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years.
* Diagnosis of Type 2 Diabetes Mellitus.
* Patients with a glycated hemoglobin (HbA1c) level \> 7%.
* Ability to comply with all required examinations and provide signed informed consent.

Exclusion Criteria:

* No previous diabetic fundus examination.
* No known diabetic retinopathy.
* Absence of other ocular diseases that could lead to retinopathy.
* Subjects from whom clear fundus photographs could not be obtained.
* Patients with comorbid malignant tumors or severe cardiovascular diseases.
* Patients anticipated to have difficulties with follow-up or those residing in other provinces.

Where it's running

  • Sichuan Academy of Medical Sciences - Sichuan Provincial People's Hospital
    Chengdu, Sichuan, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.